Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alokta Chakrabarti

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 6, 2012
Multivalent design of apoptosis-inducing bid-BH3 peptide-oligosaccharides boosts the intracellular activity at identical overall peptide concentrationsMartin Richter, Alokta Chakrabarti, Ivo R Ruttekolk, et al.
Future Medicinal Chemistry|August 31, 2016
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseasesAlokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, et al.
Trends in Pharmacological Sciences|May 28, 2015
HDAC8: a multifaceted target for therapeutic interventionsAlokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2013
Stabilization of peptides for intracellular applications by phosphoramidate-linked polyethylene glycol chainsNicole Nischan, Alokta Chakrabarti, Remigiusz A Serwa, et al.
Molecular Pharmacology|January 21, 2011
Coupling to polymeric scaffolds stabilizes biofunctional peptides for intracellular applicationsIvo R Ruttekolk, Alokta Chakrabarti, Martin Richter, et al.
Journal of Chemical Information and Modeling|September 23, 2014
Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validationSrinivasaraghavan Kannan, Jelena Melesina, Alexander-Thomas Hauser, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversityBertrand Lecointre, Remy Narozny, Maria Teresa Borrello, et al.
Chemmedchem|December 10, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 InhibitorsDmitrii V Kalinin, Sunit K Jana, Maxim Pfafenrot, et al.
Archiv Der Pharmazie|June 23, 2017
Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoniKatharina Stenzel, Alokta Chakrabarti, Jelena Melesina, et al.
Molecules (Basel, Switzerland)|March 3, 2018
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro TestingConrad V Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 6, 2012
Multivalent design of apoptosis-inducing bid-BH3 peptide-oligosaccharides boosts the intracellular activity at identical overall peptide concentrationsMartin Richter, Alokta Chakrabarti, Ivo R Ruttekolk, et al.
Future Medicinal Chemistry|August 31, 2016
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseasesAlokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, et al.
Trends in Pharmacological Sciences|May 28, 2015
HDAC8: a multifaceted target for therapeutic interventionsAlokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2013
Stabilization of peptides for intracellular applications by phosphoramidate-linked polyethylene glycol chainsNicole Nischan, Alokta Chakrabarti, Remigiusz A Serwa, et al.
Molecular Pharmacology|January 21, 2011
Coupling to polymeric scaffolds stabilizes biofunctional peptides for intracellular applicationsIvo R Ruttekolk, Alokta Chakrabarti, Martin Richter, et al.
Journal of Chemical Information and Modeling|September 23, 2014
Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validationSrinivasaraghavan Kannan, Jelena Melesina, Alexander-Thomas Hauser, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversityBertrand Lecointre, Remy Narozny, Maria Teresa Borrello, et al.
Chemmedchem|December 10, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 InhibitorsDmitrii V Kalinin, Sunit K Jana, Maxim Pfafenrot, et al.
Archiv Der Pharmazie|June 23, 2017
Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoniKatharina Stenzel, Alokta Chakrabarti, Jelena Melesina, et al.
Molecules (Basel, Switzerland)|March 3, 2018
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro TestingConrad V Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Pageof 2